SCHEMBL9954504

SCHEMBL9954504

CCCCCCCCCCCCCCCCC(O)(CCCCCCCC(C)C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 1/20 0.45
BLM P54132 1/20 0.45
HSPE1 P61604 1/20 0.45
ACE2 Q9BYF1 1/20 0.44
GPR84 Q9NQS5 7/20 0.44
FFAR1 O14842 1/20 0.44
MAPT P10636 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28963520 0.88 FFAR4 (0.40) HSPD1BLMHSPE1FFAR1MEN1
SCHEMBL28679729 0.87 HSPD1 (0.46) HSPD1BLMHSPE1ACE2GPR84
SCHEMBL8376643 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL8376447 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL4803586 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL380072 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL9766363 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL380990 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL9222591 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A
SCHEMBL11351778 0.87 FDPS (0.48) GPR84FFAR1PPARDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed